HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1-(3,4,5-trihydroxyphenyl)nonan-1-one

a ligand for TR3 orphan nuclear receptor; structure in first source

Also Known As:

THPN compound

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Ketones: 2618
  - 1-(3,4,5-trihydroxyphenyl)nonan-1-one: 1
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenols: 677
        Pyrogallol: 83
        1-(3,4,5-trihydroxyphenyl)nonan-1-one: 1

Experts

1.	Bian, Xue-li: 1 article (08/2015)
2.	Cai, Qi-xu: 1 article (08/2015)
3.	Chen, Hang-zi: 1 article (08/2015)
4.	He, Jian-ping: 1 article (08/2015)
5.	Hou, Pei-pei: 1 article (08/2015)
6.	Huang, Pei-qiang: 1 article (08/2015)
7.	Li, Feng-wei: 1 article (08/2015)
8.	Lin, Tianwei: 1 article (08/2015)
9.	Wang, Wei-jia: 1 article (08/2015)
10.	Wang, Yuan: 1 article (08/2015)

Related Diseases

1.	Neoplasms (Cancer) 08/20/2015 - "We previously reported that autophagic cell death mediated by nuclear receptor TR3 and driven by a chemical agonist, 1-(3,4,5-trihydroxyphenyl)nonan-1-one (THPN), is highly effective in the therapy of melanoma but not any other cancer types. "
2.	Melanoma (Melanoma, Malignant) 08/20/2015 - "We previously reported that autophagic cell death mediated by nuclear receptor TR3 and driven by a chemical agonist, 1-(3,4,5-trihydroxyphenyl)nonan-1-one (THPN), is highly effective in the therapy of melanoma but not any other cancer types. "

Related Drugs and Biologics

1.	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)

Related Therapies and Procedures

1.	Therapeutics